Field & Main Bank’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161K Sell
2,257
-30
-1% -$2.37K 0.05% 131
2025
Q4
$188K Sell
2,287
-30
-1% -$2.34K 0.05% 130
2025
Q3
$174K Buy
2,317
+50
+2% +$3.73K 0.05% 137
2025
Q2
$168K Sell
2,267
-90
-4% -$6.26K 0.05% 135
2025
Q1
$190K Sell
2,357
-160
-6% -$13.8K 0.07% 128
2024
Q4
$197K Buy
2,517
+60
+2% +$5.1K 0.07% 123
2024
Q3
$231K Sell
2,457
-50
-2% -$4.2K 0.08% 121
2024
Q2
$195K Buy
2,507
+25
+1% +$2.04K 0.07% 125
2024
Q1
$226K Sell
2,482
-599
-19% -$49.8K 0.09% 122
2023
Q4
$238K Buy
3,081
+27
+0.9% +$1.89K 0.1% 117
2023
Q3
$208K Buy
3,054
+2,031
+199% +$148K 0.1% 124
2023
Q2
$83.1K Buy
1,023
+383
+60% +$30.6K 0.05% 150
2023
Q1
$52.5K Buy
+640
New +$45.7K 0.03% 168

Other funds holding GEHC

Field & Main Bank's GEHC Position: Q1 2026 in Review

Field & Main Bank reduced its GE HealthCare (GEHC) stake by 1.3% in Q1 2026, selling an estimated $2.37K and leaving 2,257 shares worth $161K. The position accounts for 0.05% of the portfolio, ranked #131.

Field & Main Bank first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $238K in Q4 2023. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Field & Main Bank held 2,257 shares of GE HealthCare worth $161K as of Q1 2026.
  • Field & Main Bank sold 30 GE HealthCare shares in Q1 2026, an estimated $2.37K.
  • GE HealthCare made up 0.05% of Field & Main Bank's portfolio in Q1 2026, its #131 holding.
  • Field & Main Bank first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Field & Main Bank's GE HealthCare position peaked at $238K in Q4 2023.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.